Haruo Naito
Chief Executive Officer at EISAI CO., LTD.
Net worth: 27 M $ as of 2024-04-29
Network origin in Haruo Naito first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 87 | |
The Naito Foundation
1
| Foundation/Endowment | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Haruo Naito via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Pharmaceuticals: Major | Chief Executive Officer Chairman Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Chief Executive Officer | |
Sunplanet Co., Ltd.
 Sunplanet Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Eisai Co., Ltd., Sunplanet Co., Ltd. is a Japanese company that provides facility management, pharmaceutical analysis, and research development services. The private company is based in Tokyo, Japan and was founded in 2001. | Miscellaneous Commercial Services | President Director/Board Member President Director/Board Member | |
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The private company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Pharmaceuticals: Major | President Chief Executive Officer Director/Board Member Chief Executive Officer | |
| University of Hitotsubashi | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
Eisai Ltd. (United Kingdom)
 Eisai Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Eisai Ltd. (United Kingdom) is a pharmaceutical company based in Hatfield, UK. Part of Eisai Co., Ltd., Eisai Ltd. prioritizes patients and their families by continually improving the benefits that healthcare can provide. The British company was founded in 1988 and Gary Bryan Hendler has been the CEO of the company since 2008. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| NTT DATA CORPORATION | Miscellaneous Commercial Services | President Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
| Meiji University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Sumitomo Mitsui Banking Corp.
 Sumitomo Mitsui Banking Corp. Major BanksFinance Sumitomo Mitsui Banking Corp. engages in the provision of financial services centered on banking. It operates through the following business segments: Wholesale, Retail, International, Market Sales, and Headquarters Management. The Wholesale segment covers business for customers of large and medium-sized companies in Japan. The Retail segment handles business for domestic individuals and SME customers. The International segment comprises of business for overseas Japanese and non-Japanese companies. The Market Sales segment corresponds to financial market business. The Headquarters Management segment includes all other businesses not covered by other segments. The company was founded in April 2001 and is headquartered in Tokyo, Japan. | Major Banks | Director/Board Member Chief Executive Officer | |
Eisai R&D Management Co., Ltd.
 Eisai R&D Management Co., Ltd. BiotechnologyHealth Technology Part of Eisai Co., Ltd., Eisai R&D Management Co., Ltd. engages in research and development of pharmaceuticals. The private company is based in Bunkyo, Japan. | Biotechnology | President President | |
EA Pharma Co., Ltd.
 EA Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., EA Pharma Co., Ltd. is a specialty pharmaceutical company based in Tokyo, Japan. The Japanese company specializes in digestive diseases such as inflammatory intestinal diseases and focuses on advanced research and development and marketing activities to solve unmet medical needs. EA Pharma Co. provides drug discovery research, development research related to gastrointestinal diseases, and drug discovery base technology research to meet the further medical needs of patients. The private company's production department aims to create products that have effective and safety as a drug and ensure the quality of the product. EA Pharma Co. aims to be the largest digestive pharmacy in Japan, which was born in the integration of the digestive business of the Eisai group and the Ajinomoto group's digestive business. | Pharmaceuticals: Major | Director/Board Member President | |
Eisai Farmacéutica SA
 Eisai Farmacéutica SA Pharmaceuticals: MajorHealth Technology Eisai Farmacéutica SA is a pharmaceutical company based in Madrid, Spain. Eisai Farmacéutica SA operates as a Spanish pharmaceutical company. Part of Eisai Co., Ltd., the private company was founded in 2001. The CEO is Gary Bryan Hendler. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Eisai Manufacturing Ltd.
 Eisai Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Manufacturing Ltd. is a pharmaceutical company based in Hatfield, UK. The British company's focus is on developing new medicines for neglected tropical diseases and malaria, improving access to medicines for non-communicable diseases, and promoting sustainability. Eisai Manufacturing is committed to funding the 3rd phase of health innovative technology fund activities. The private company's official corporate website provides information on their initiatives and HHC concept. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Eisai China, Inc.
 Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Eisai China, lnc. engages in the manufacture of pharmaceutical products. It offers medicines for digestive, endocrine, orthopedic, and cancer diseases. The company was founded on March 28, 1996 and is headquartered in Suzhou, China. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| MITSUBISHI SHOKUHIN CO., LTD. | Food Distributors | Director/Board Member Director/Board Member | |
| Keio University | College/University | Undergraduate Degree Corporate Officer/Principal | |
Eisai GmbH
 Eisai GmbH Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai GmbH is a German pharmaceutical company that specializes in research and development of innovative treatments for neurological and oncological diseases. The private company is based in Frankfurt, Germany. The CEOs of the company are Gary Bryan Hendler, Nicholas Conrad Burgin. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
Sumitomo Life Insurance Co.
 Sumitomo Life Insurance Co. Life/Health InsuranceFinance Sumitomo Life Insurance Co. engages in the provision of life insurance services. It also sells investment trust and manages defined contribution pension plans. The company was founded in May 1907 and is headquartered in Osaka, Japan. | Life/Health Insurance | Director/Board Member Director/Board Member | |
| SCSK CORPORATION | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Drexel University College of Medicine | College/University | Doctorate Degree | |
| Lycoming College | College/University | Undergraduate Degree | |
| DAIWA SECURITIES GROUP INC. | Investment Banks/Brokers | Director/Board Member | |
| MEGMILK SNOW BRAND CO.,LTD. | Food: Meat/Fish/Dairy | Director/Board Member | |
Miura & Partners
 Miura & Partners Miscellaneous Commercial ServicesCommercial Services Miura & Partners is a law office that provides the best results to clients. The private company is based in Tokyo, Japan. The Japanese company has a team of experienced lawyers and staff who utilize their knowledge and know-how to serve their clients effectively. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pacific Consultants Co., Ltd.
 Pacific Consultants Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Pacific Consultants Co., Ltd. provides integrated construction consulting services in engineering and infrastructure design. Its services include the land conservation, transport infrastructure, facility engineering, public management, information systems, project planning, energy and environment, geotechnical, business development, research and development; and others. The company was founded on September 4, 1951 and is headquartered in Tokyo, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
| TECHMATRIX CORPORATION | Information Technology Services | Director/Board Member | |
| Brandeis University | College/University | Doctorate Degree | |
| Harvard Business School | College/University | Masters Business Admin | |
| Adat, Inc. | Director/Board Member | ||
Nextpoint Therapeutics, Inc.
 Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chief Executive Officer | |
| The Japanese Association of Medical Sciences | Director/Board Member | ||
| Senshin Medical Research Foundation | Director/Board Member | ||
| Foundation for Promotion of Medical Training | Director/Board Member | ||
Musashi Academy of The Nezu Foundation
 Musashi Academy of The Nezu Foundation Other Consumer ServicesConsumer Services Musashi Academy of The Nezu Foundation engages in the operation of high school, junior high school and university. The company was founded by Kaichiro Nezu in 1922 and is headquartered in Tokyo, Japan. | Other Consumer Services | Director/Board Member | |
| SUMITOMO MITSUI FINANCIAL GROUP, INC. | Major Banks | Chairman | |
| Waseda University | College/University | Corporate Officer/Principal | |
Eisai SAS
 Eisai SAS Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai SAS is a French pharmaceutical company founded in 1996. The private company is based in Courbevoie, France and strives to improve the lives of those who could benefit from their medicines. Eisai focuses its research on oncology and neurology, two areas presenting challenges in terms of public health. The company is committed to the fight against serious diseases, alongside patients, healthcare professionals, and public authorities. | Pharmaceuticals: Major | Chairman | |
Japanese Chamber of Commerce & Industry of New York, Inc.
 Japanese Chamber of Commerce & Industry of New York, Inc. Miscellaneous Commercial ServicesCommercial Services Japanese Chamber of Commerce Industry of New York, Inc. is non-profit organization that engages in facilitation of trade between the U.S. and Japan. The company was founded on November 14, 1932 by 14 prominent Japanese businessman, and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| YAMADA CORPORATION | Industrial Machinery | Director/Board Member | |
KFE Japan Co., Ltd.
 KFE Japan Co., Ltd. Electronics DistributorsDistribution Services KFE Japan Co., Ltd. distributes electronic components and consumer electronics. It offers printed circuit boards, eco-bikes, biomass plastic molds, and three-dimensional products. The company was founded on September 10, 1997 and is headquartered in Tokyo, Japan. | Electronics Distributors | Director/Board Member | |
| Veranova LP | Corporate Officer/Principal | ||
Tokyo Cathode Laboratory Co., Ltd.
 Tokyo Cathode Laboratory Co., Ltd. SemiconductorsElectronic Technology Tokyo Cathode Laboratory Co., Ltd. engages in the manufacture and sale of materials and components for electronic equipment. It operates through the Probe Card Business and Electronic Components Business segments: The Probe Card Business segment includes parts for electron tubes, evaporation devices, implantation process parts, aluminum for etchers, and silicon electrodes. The Probe Card Business segment includes probe cards for integrated circuits, vertical probe cards, and probe pins. The company was founded in May 1950 and is headquartered in Tokyo, Japan. | Semiconductors | Director/Board Member | |
| ANRITSU CORPORATION | Electronic Equipment/Instruments | Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
| University of Massachusetts | College/University | Graduate Degree | |
| Russell Reynolds Associates Japan, Inc. | Director/Board Member | ||
| MERSANA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal |
Statistics
International
| Japan | 30 |
| United States | 16 |
| United Kingdom | 3 |
| Spain | 2 |
| China | 2 |
Sectoral
| Health Technology | 15 |
| Consumer Services | 12 |
| Commercial Services | 8 |
| Finance | 6 |
| Distribution Services | 3 |
Operational
| Director/Board Member | 145 |
| Corporate Officer/Principal | 84 |
| Independent Dir/Board Member | 58 |
| President | 27 |
| Chairman | 25 |
Most connected contacts
| Insiders | |
|---|---|
| Santiago Arroyo | 14 |
| Yasuo Ikeda | 12 |
| Kimitoshi Yabuki | 10 |
| Yuko Yasuda | 10 |
| Christina L Ahmadjian | 10 |
| Toru Yamashita | 8 |
| Lonnel Coats | 8 |
| Ann Miller | 8 |
| Michikazu Aoi | 7 |
| Ivan Cheung | 7 |
| Emile Farhan | 7 |
| Ademir Sarcevic | 7 |
| Koichi Masuda | 7 |
| Daiken Tsunoda | 6 |
| Fumihiko Ike | 6 |
- Stock Market
- Insiders
- Haruo Naito
- Company connections
